首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1439219

全球連續性腎臟替代治療設備 (CRRT) 市場：洞察、競爭格局、市場預測：2030 年

Continuous Renal Replacement Therapy Machines (CRRT) - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

2023年全球連續性腎臟替代治療（CRRT）設備市場規模為12.5億美元。預計到 2030 年，該市場將達到 19.2 億美元，2024-2030 年預測期間複合年增長率為 7.39%。全球範圍內急性腎衰竭或急性腎損傷(AKI) 盛行率不斷上升，以及發生AKI 的ICU 患者負擔隨著膿毒症發病率的增加而增加，推動了對CRRT 設備的需求。這在很大程度上歸功於重大的技術進步在產品線。 CRRT 相對於間歇性血液淨化系統的臨床優勢也是 CRRT 設備市場的一個突出驅動因素。

急性腎損傷（AKI）是所有住院患者最常見的嚴重併發症之一，其發生率在住院患者尤其是重症監護病房的患者中呈上升趨勢。此外，潛在的慢性腎臟疾病被認為是 AKI 的危險因子。此外，根據 2020 年《刺胳針》發表的一項研究，2017 年記錄了 6.975 億個各階段 CKD 病例，約 120 萬人因此死亡。透過 CRRT 設備進行適當和及時的治療可能會降低慢性腎損傷盛行率和相關死亡率的增加。對於血流動力學不穩定的 AKI 重症患者，CRRT 設備透過在 24 小時內緩慢清除體液和尿毒症毒素並將清潔的血液送回體內來支持腎臟。因此，有助於 CRRT 全球市場的成長。

此外，自連續性腎臟替代療法出現以來，以高滲透壓血液濾過和高容量滲透性為主的各種技術進步也有望推動全球 CRRT 市場的發展。

目前，製造商正在開發精密設備，在 CRRT 手術期間提供安全可靠的效能。此外，這些儀器配備了易於使用的介面，可輕鬆進行操作。例如，最近在 2022 年，百特宣布推出 PrisMax 2，這是其下一代 CRRT 平台的最新版本。 PrisMax 2 系統採用了該公司TrueVue 數位健康產品組合中的新解決方案，可簡化連續腎臟替代療法(CRRT) 和其他器官支持療法的實施，同時還改進了重症監護病房(ICU) 的性能，旨在讓醫院能夠靈活地滿足他們的獨特需求。這些因素正在推動全球 CRRT 設備市場的擴張。

本報告調查了全球連續性腎臟替代治療設備 (CRRT) 市場，並按產品類型、模式、患者、最終用戶、地區和市場滲透率提供了市場概述。我們提供公司配置文件等等。

Continuous Renal Replacement Therapy (CRRT) Machines Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult And Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography is projected to grow at a constant CAGR during the forecast period from 2024-2030 on account of significant technological advancement and rising prevalence of acute renal failure.

Global Continuous Renal Replacement Therapy (CRRT) Machines Market was valued at USD 1.25 billion in 2023, growing at a CAGR of 7.39% during the forecast period from 2024 to 2030, to reach USD 1.92 billion by 2030. The demand for CRRT machines is predominantly attributed to the rise in the prevalence of acute renal failure or Acute Kidney Injury (AKI) across the globe, the growing burden of ICU patients with AKI along with an increase in the incidence of sepsis, significant technological advancements in the product line. The clinical advantage of CRRT over intermittent blood purification systems is also a prominent driving factor for the CRRT machines market.

CRRT Machines Market Dynamics:

Acute kidney injury (AKI) is one of the most common serious complications for all hospital admissions, with its incidence increasing among hospitalized patients, particularly those in the intensive care unit. Moreover, it is recognized that underlying chronic kidney disease is a risk factor for AKI. Also, according to a study published in LANCET 2020, in 2017, 697.5 million cases of all-stage CKD were recorded and around 1.2 million died from the indication. The rising prevalence of chronic kidney disorders and their associated deaths could have been reduced through proper and timely treatment through CRRT machines as these machines provide renal support by slowly removing fluid and uremic toxins and returning clean blood to the body over 24 hours duration in critically ill patients suffering from AKI and are hemodynamically unstable. Thus, contributing to the growth of the Global CRRT market.

Furthermore, various technological advancement which mainly comprises high permeability hemofiltration and high volume permeability since the advent of continuous renal replacement therapy is also expected to boost the global CRRT market.

At present, manufacturers are developing precise devices that are safe and give reliable performance during CRRT procedures. Also, for easy performance, these devices are equipped with a user-friendly interface. For instance, recently, in 2022, Baxter announced the launch of its latest version of the next-generation CRRT platform, PrisMax 2. The PrisMax 2 system features new solutions within the company's TrueVue digital health portfolio and is designed to help simplify the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). Thus, such factors are contributing to the upsurge of the global CRRT machines market.

However, certain factors such as the high procedural cost of CRRT are likely to pose a minor hurdle to the growth of the CRRT market.

CRRT Machines Market Segment Analysis:

CRRT Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult and Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the CRRT market modality segment, Continuous Venovenous Hemofiltration (CVVH) holds the highest market. This is owing to the rising incidence of fluid overloads that are frequently found in patients with acute kidney injuries and in the ICU. However, it is also expected that Continuous Venovenous Hemodiafiltration (CVVHDF) will observe lucrative growth during the forecasted period. This is because the CVVHDF treatment modality results in the complete removal of solutes and fluids from the blood as it combines both the principle of convection and diffusion i.e., hemofiltration and hemodialysis by making use of a highly efficient hemofilter for the removal of solute and fluid. Thereby propelling the segmental growth of the CRRT market.

Moreover, most of CRRT machines are compatible with more than two or three modalities which can further fuel the market. In 2019, Baxter launched PrisMax system the company's platform for continuous renal replacement therapy (CRRT), therapeutic plasma exchange (TPE), and organ support therapies (OST). The system delivers all therapy modalities of CRRT and therapeutic plasma exchange (TPE) without additional equipment. Hence, these factors are responsible for the growth of the CVVH modality systems along with CVVHDF modalities during the forecasted period.

North America is expected to dominate the overall CRRT Machines Market:

Among all the regions, North America is expected to dominate the overall CRRT machines market during the forecast period. This domination is due to the growing demand for advanced technologies in CRRT machines, the increasing cases of CKD and associated AKIs in the region are driving regional growth.

Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong R&D expenditure by the key players. Rising product launch and commercialization agreements among the key manufacturers are also anticipated to boost the CRRT market. For instance, the recent launch of the first and only Pediatric and Neonatal Acute Dialysis Machine (Carpediem(TM) systems) in December 2020 which is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms in the United States is likely to grow the market in the region.

In addition, the integration of telehealth platforms to improve outcomes and the care experience for CKD patients deciding to treat at home is also expected to fuel the market in the region. For instance, in 2019, DaVita incorporated its connective technologies DaVita Care Connect into its home dialysis program to meet the latest COVID-19 regulations implemented by the government to prevent the transmission of infection.

Europe and Asia-Pacific region have the future potential growth for global CRRT machines. This is due to the increasing incidence and prevalence of AKI and rising government initiatives to increase awareness about the advancements in renal therapy which is likely to surge the market. According to the International Society of Nephrology 2022, every year, there are around 13.3 million cases of AKI and the burden is specifically high in emerging countries where the annual incidence is estimated to be 11.3 million.

Therefore, this situation is giving rise to a critical need for CRRT machines thereby augmenting the CRRT market in this region. Moreover, rapid urbanization, an increase in disposable income in emerging countries such as China, India, and others, and the presence of local manufacturers in the region are also projected to drive the global CRRT market.

CRRT Machines Market Key Players:

Some of the key market players operating in the CRRT machines market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Informed SA, Medtronic, and others.

Recent Developmental Activities in CRRT Machines Market:

In August 2020, Baxter obtained US FDA Emergency Use Authorization for Regiocit Replacement Solution used In CRRT.

In April 2020, Fresenius Medical Care received US FDA Emergency Use Authorization for multiFiltrate PRO System and multiBic/multiPlus Solutions to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.

Key Takeaways from the CRRT Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CRRT machines market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global CRRT machines Market.

Various opportunities available for the other competitor in the CRRT machines Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for CRRT Machines market growth in the coming future?

Target Audience who can be benefited from CRRT Machines Market Report Study

CRRT machines providers

Research organizations and consulting companies

CRRT machines-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in CRRT Machines

Various End-users who want to know more about the CRRT machines Market and latest technological developments in the CRRT machines market.

Frequently Asked Questions for CRRT Machines Market

What is CRRT Machine?

CRRT machines are used in blood purification therapy in patients suffering with acute renal failure or acute kidney injuries. The machine pumps and controls the rate of blood flow and includes software to safely monitor therapy delivery. These machines are available in four different modes: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF.

What are the drivers for the Global CRRT Machines Market?

The major factors fuelling the demand for CRRT machines are the rising prevalence of acute renal failure, the growing burden of acute kidney injuries among ICU patients, new product approvals, and the shifting focus of key players for developing advanced products.

What is the market for Global CRRT Machines?

What are the key players operating in the global CRRT Machines Market?

What regions have the highest share in the CRRT Machines market?

North America is expected to dominate the overall CRRT Machines market during the forecast period, 2024 to 2030 due to the advanced healthcare system, increasing prevalence of chronic kidney disorders in the region, and rising product developmental activities among the key market players.

1. CRRT Machines Market Report Introduction

2. CRRT Machines Market Executive Summary

2.1. Scope of the Study
2.2. Market at a Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. CRRT Machines Market Key Factor Analysis

4.1 CRRT Machines Market Drivers
- 4.1.1 Increasing Incidence of Acute Kidney Injury (AKI)
- 4.1.2 Increasing Clinical Advantage of CRRT Over Intermittent Blood Purification
- 4.1.3 Technological Advancement and New Product Launches
- 4.1.4 Growing Number of ICU Patients with AKI
4.2 CRRT Machines Market Restraints and Challenges
- 4.2.1 Stringent Regulatory Guidelines
- 4.2.2 High Procedural Cost of CRRT
4.3 CRRT Machines Market Opportunities
- 4.3.1 Development of CRRT Systems for Pediatric Patients
- 4.3.2 Growth Opportunities in emerging countries

5. CRRT Machines Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. CRRT Machines Market layout

6.1 By Product Type
- 6.1.1 Machines
- 6.1.2 Consumables
6.2 By Modality
- 6.2.1 Slow Continuous Ultrafiltration (SCUF)
- 6.2.2 Continuous Venovenous Hemofiltration (CVVH)
- 6.2.3 Continuous Venovenous Hemodialysis (CVVHD)
- 6.2.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
6.3 By Patient
- 6.3.1 Adults
- 6.3.2 Pediatrics
6.4 By End-User
- 6.4.1 Hospitals
- 6.4.2 Dialysis Centers
- 6.4.3 Others
6.5 By Geography
- 6.5.1 North America CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.1.1. United States CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.1.2. Canada CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.1.3. Mexico CRRT Machines Market Size in USD million (2021-2030)
- 6.5.2 Europe CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.1 France CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.2 Germany CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.3 United Kingdom CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.4 Italy CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.5 Spain CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.6 Rest of Europe CRRT Machines Market Size in USD million (2021-2030)
- 6.5.3 Asia-Pacific CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.1 China CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.2 Japan CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.3 India CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.4 Australia CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.5 South Korea CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.6 Rest of Asia-Pacific CRRT Machines Market Size in USD million (2021-2030)
- 6.5.4 Rest of the World (RoW) CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.4.1 Middle East CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.4.2 Africa CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.4.3 South America CRRT Machines Market Size in USD million (2021-2030)

7. CRRT Machines Company and Product Profiles

7.1 Baxter International Inc.
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2 Fresenius Medical Care AG & Co. KGaA
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3 NIKKISO CO., LTD.
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4 B. Braun Melsungen AG
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5 Asahi Kasei Corporation
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6 Infomed SA
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7 Medtronic
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8 NxStage Medical, Inc.
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9 Medica S.p.A.
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10 SWS Hemodialysis Care Co., Ltd.
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11 Dialco Medical Inc.
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12 Anjue Medical Equipment Co. Ltd.
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13 Medica S.p.A.
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14 Jiangxi Sanxin Medtec Co. Ltd.
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy